The initial objective of pharmacologic endoprosthesis was to reduce excessive myointimal hyperplasia, the main culprit in coronary restenosis .
Las endoprótesis farmacológicas fueron idealizadas para inicialmente, reducir la hiperplasia miointimal excesiva, la principal promotora de la re-estenosis coronaria .
As endopróteses farmacológicas foram idealizadas com a finalidade inicial de diminuir a hiperplasia miointimal excessiva, principal promotora da reestenose coronária .